287C246C256
For oral vs injectable route evidence, see BPC-157 Oral vs Injectable
Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds.. Regulatory toxicology and pharmacology : RTP.Study breakdown PubMed 9RPEP-02350Chang, Chung-Hsun et al
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
While vitamin injections are widely available, they should always be done under the supervision of a healthcare professional to ensure the correct dosage, sterile conditions, and proper technique
Contact IV Lounge today at (959)900-1100 or complete the form to get started